치매 진단 검사법의 비용-효과성에 대한 체계적 문헌 고찰 = COST-EFFECTIVENESS OF DIAGNOSTIC TECHNOLOGIES FOR DEMENTIA: A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS

다국어 초록 (Multilingual Abstract)

The objective of this study is to systematically review the economic evaluations of diagnosing dementia and to suggest appropriate economic model for diagnosing dementia. We focused on the methodological quality and features of decision models dealing with new technologies for diagnosing dementia. Ovid-MEDLINE, EMBASE, Cochrane Library, KoreaMed, KMBase, and KISS were searched for English or Korean language publications. Selected studies were assessed using the framework for quality assessment of decision-analytic models. Initially, 2,648 studies were identified and we finally selected 11 studies. Among the selected studies, there were 4 studies dealing with CT or MRI, 3 for dynamic susceptibility-weighted contrast-enhanced MRI and/or single photon emission computed tomography, 2 for FDG PET, 2 for amyloid PET, and 1 for biomarkers in cerebrospinal fluid. In terms of the type of decision models, only 1 study used Bayesian decision tree, another one used discrete event simulation, and the others used decision tree models. The results of the quality assessment showed that most studies did not meet the criteria of the framework enough. Therefore future decision-analytic models for diagnosing dementia should be designed to describe the scope of model and the diagnostic options in detail and to evaluate uncertainty extensively.

참고문헌 (Reference)

1 한국보건의료연구원, "치매진단에 있어 뇌 FDG PET검사의 진단적 유용성 평가 연구" 2013

2 보건복지부 노인성치매 임상연구센터, "치매임상진료지침 제1부: 진단 및 평가" 보건복지부 2011

3 보건복지부, "치매노인실태조사" 2011

4 국회예산정책처, "치매관리사업의 현황과 개선과제" 2014

5 통계청, "장래인구추계" 2014

6 보건복지부 중앙치매센터, "대한민국 치매현황 2016" 보건복지부 2016

7 보건복지부, "노인보건복지사업안내" 2017

8 통계청, "가계동향조사" 2015

9 Knottnerus, J. A., "The evidence base of clinical diagnosis: Theory and methods of diagnostic research" Wiley-Blackwell 2009

10 Van den Bruel, A., "The evaluation of diagnostic tests: evidence on technical and diagnostic accuracy, impact on patient outcome and cost-effectiveness is needed" 60 (60): 1116-1122, 2007

11 Albert, M. S., "The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease" 7 (7): 270-279, 2011

12 Bermingham, S., "The appropriate use of neuroimaging in the diagnostic work-up of dementia: an economic literature review and cost-effectiveness analysis" 14 (14): 1-67, 2014

13 World Health Organization(WHO), "The ICD-10 classification of mental and behavioural disorders" Diagnostic Criteria for Research 1993

14 Karnon, J., "Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–4" 32 (32): 701-711, 2012

15 Drummond, M. F., "Methods for the economic evaluation of health care programmes" Oxford University Press 2015

16 Philips, Z., "Good practice guidelines for decision-analytic modelling in health technology assessment" 24 (24): 355-371, 2006

17 Guo, S., "Florbetaben PET in the early diagnosis of alzheimer's disease: A discrete event simulation to explore its potential value and key data gaps" 2012

18 Dixon, J., "Exploring the cost-effectiveness of a one-off screen for dementia (for people aged 75years in England and Wales)" 30 (30): 446-452, 2014

19 Silverman, D. H.,․, "Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits" 43 (43): 253-266, 2002

20 Tan, C. C., "Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis" 41 (41): 615-631, 2014

21 Hansen, R. A., "Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: a systematic review and meta-analysis" 3 (3): 211-225, 2008

22 LaFrance, N. D., "Dynamic susceptibility contrast MR imaging for the evaluation of probable Alzheimer disease: a cost-effectiveness analysis" 5 (5): S231-S233, 1998

23 Handels, R. L., "Diagnosing Alzheimer's disease: a systematic review of economic evaluations" 10 (10): 225-237, 2014

24 Shizuo Hatashita, "Diagnosed Mild Cognitive Impairment Due to Alzheimer’s Disease with PET Biomarkers of Beta Amyloid and Neuronal Dysfunction" Public Library of Science (PLoS) 8 (8): e66877-, 2013

25 Briggs, A. H., "Decision modelling for health economic evaluation" Oxford University Press 2006

26 Schaafsma, J. D., "Decision analysis to complete diagnostic research by closing the gap between test characteristics and cost-effectiveness" 62 (62): 1248-1252, 2009

27 Valcarcel-Nazco. C., "Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease" 42 (42): 777-788, 2014

28 Yu SY, "Cost-effectiveness of nationwide opportunistic screening program for dementia in South Korea" 44 (44): 195-204, 2015

29 Biasutti, M., "Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease" 7 (7): e35559-, 2012

30 McMahon PM․, "Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease" 217 (217): 58-68, 2000

31 Simon, D. G., "Cost-effectiveness of computerized tomography and magnetic resonance imaging in dementia" 5 (5): 335-354, 1985

32 McMahon, P. M., "Cost-effectiveness of PET in the diagnosis of Alzheimer disease" 228 (228): 515-522, 2003

33 Moulin-Romsee, G., "Cost-effectiveness of 18F-fluorodeoxyglucose positron emission tomography in the assessment of early dementia from a Belgian and European perspective" 12 (12): 254-263, 2005

34 Hornberger, J., "Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective" 18 (18): 63-73, 2015

35 Getsios, D., "Cost effectiveness of donepezil in the treatment of mild to moderate Alzheimer’s disease" 28 (28): 411-427, 2010

36 Getsios, D., "An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom" 8 (8): 22-30, 2012